Back to Results
First PageMeta Content
Muscular dystrophy / Congenital muscular dystrophy / Omigapil / Bethlem myopathy / Neuromuscular disease / Novartis / Muscle / Anatomy / Health / Biology


Development of SNT-317 (INN: omigapil) in CMD and other neuromuscular diseases
Add to Reading List

Document Date: 2007-07-02 00:31:52


Open Document

File Size: 297,75 KB

Share Result on Facebook

Company

Novartis / /

Event

FDA Phase / Security Buyback / /

MedicalCondition

CMD / neuromuscular diseases / ALS / /

Product

SNT-317 / /

SocialTag